Cellular Iron Metabolism in Health and Diseased

References

• Williams R. J. P. Natural selection of the chemical elements. Proc. Roy. Sot. Lond. B. 1981; 213: 361–397
   Web of Science ®Google Scholar
• Wackett L. P., Orme-Johnson W. H., Walsh C. T. Transition metal enzymes in bacterial metabolism. Metal Ions and Bacteria, T. J. Beveridge, R. J. Doyle. J. Wiley & Sons, New York 1989; 165–206
   Google Scholar
• Weinberg E. D. Cellular regulation of iron assimilation. Quart. Rev. Biol. 1989; 64: 261–290
   PubMed Web of Science ®Google Scholar
• Sprott G. D. Inorganic ion gradients in methanogenic archebacteria. Metal Ions and Bacteria, T. J. Beveridge, R. J. Doyle. J. Wiley and Sons, New York 1989; 91–120
   Google Scholar
• Swinburne T. R. Stimulation of disease development by siderophores and inhibition by chelated iron. Iron, Siderophores, and Plant Diseases, T. R. Swinburne. Plenum Press, New York 1986; 217–226
   Google Scholar
• Weinberg E. D. Roles of trace metals in transcriptional control of microbial secondary metabolism and differentiation. Biology Metals 1990; 2: 191–196
   PubMedGoogle Scholar
• Stevens R. G., Kalkwarf D. R. Iron, radiation, and cancer. Environ. Health Persp. 1990; 87
   Google Scholar
• Loeb L. A., James E. A., Waltersdorph A. M., Klebanoff S. J. Mutagenesis by the autoxidation of iron with isolated DNA. Proc. Natl. Acad. Sci. 1988; 85: 3918–3922
   PubMed Web of Science ®Google Scholar
• Cerutti P. A. Prooxidant states and tumor promotion. Science 1985; 227: 375–380
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. Iron and neoplasia. Biol. Tr. El. Res. 1981; 3: 55–80
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. Iron withholding: a defense against infection and neoplasia. Physiol. Revs. 1984; 64: 65–102
   PubMed Web of Science ®Google Scholar
• de Sousa M. Immune cell functions in iron overload. Clin. exp. Immunol. 1989; 75: 1–6
   PubMed Web of Science ®Google Scholar
• Green R., Esparza I., Schreiber R. Iron inhibits the non-specific tumoricidal activity of macrophages. Ann. N.Y. Acad. Sci. 1988; 526: 301–309
   PubMed Web of Science ®Google Scholar
• Nakatsu C., Hutchinson T. C. Extreme metal and acid tolerance of Euglena mutabilis and an associated yeast from Smoking Hills, Northwest Territories, and their apparent mutualism. Microb. Ecol 1988; 16: 213–231
   PubMed Web of Science ®Google Scholar
• Romheld V., Marschner H. Evidence for a specific uptake system for iron phytosiderophores in roots of grasses. PI. Physiol 1986; 80: 175–180
   PubMed Web of Science ®Google Scholar
• Olsen R. A., Clark R. B., Bennett J. H. The enhancement of soil fertility by plant roots. Am. Scient. 1980; 69: 378–384
   Web of Science ®Google Scholar
• Scholz G., Schlesier G., Seifert K. Effect of nicotianamine on iron uptake by the tomato mutant chloronerva. Physiol. Plantar. 1985; 63: 99–104
   Web of Science ®Google Scholar
• Van Der Mark F., Bienfait F., Van Den Ende H. Variable amounts of translatable ferritin mRNA in bean leaves with various iron contents. Biochem. Biophys. Res. Commun. 1983; 115: 463–469
   PubMed Web of Science ®Google Scholar
• Stoebner J. A., Payne S. M. Iron-regulated hemolysin production and utilization of heme and hemoglobin by. Vibrio cholerae, Infec. Immun. 1988; 56: 2891–2895
   PubMed Web of Science ®Google Scholar
• Bagg A., Neilands J. B. Molecular mechanism of regulation of siderophore mediated iron assimilation. Microb. Revs. 1987; 51: 509–518
   PubMedGoogle Scholar
• Neilands J. B. Methodology of spiderophores. Struct. Bond. 1984; 58: 1–24
   Web of Science ®Google Scholar
• Byers B. R. Pathogenic iron acquisition. Life Chem. Rept. 1987; 4: 143–159
   Google Scholar
• Neilands J. B. Siderophore systems of bacteria and fungi. Metal Ions and Baceria, T. J. Beveridge, R. J. Doyle. J. Wiley & Sons, New York 1989; 141–164
   Google Scholar
• Page W. J., Huyer M. Derepression of Azotobacter vinelandii siderphore system using iron-containing minerals to limit iron repletion. J. Bacterial. 1984; 158: 496–502
   PubMed Web of Science ®Google Scholar
• Sorenson M., Sorenson S. P. L. The proteins in whey. C. R. Trav. Lab. Carlsberg Ser. Chim. 1939; 23: 55–59
   Google Scholar
• Schade A. L., Caroline L. Raw hen egg white and the role of iron in growth inhibition of Shigella dysenteriae, Staphylococcus aureus, Escherichia coli and. Saccharomyces cerevisiae., Science 1944; 100: 14–15
   Google Scholar
• Schade A. L., Caroline L. An iron binding component in human blood plasma. Science 1946; 104: 340–341
   Web of Science ®Google Scholar
• Messmer T. O. Nature of the iron requirement for Chinese hamster V79 cells in tissue culture medium. Exp. Cell Res. 1973; 77: 404–408
   PubMed Web of Science ®Google Scholar
• Pollack S., Fleming J. Plasmodium falciparum takes up iron from transferrin. Br. J. Haematol. 1984; 58: 289–293
   PubMed Web of Science ®Google Scholar
• Peterson K. M., Alderete J. P. Iron uptake and increased intracellular enzyme activity follow host lactoferrin binding by Trichomonas vaginalis receptors. J. Exp. Med. 1984; 160: 398–415
   PubMed Web of Science ®Google Scholar
• Anderson B. F., Baker H. M., Dodson E. J., Norris G. E., Rumball S. V., Waters J. M., Baker E. H. Structure of human lactoferrin at 3.2 A resolution. Proc. Natl. Acad. Sci. USA 1987; 84: 1769–1773
   PubMed Web of Science ®Google Scholar
• Bailey S., Evans R. W., Garratt R. C., Gorinsky B., Hasnain S., Horsburgh C., Jhoti H., Lindley P. F., Mydin A., Sarra R., Watson J. L. Molecular structure of serum transferrin at 3.3-A resolution. Biochemistry 1988; 27: 5804–5812
   PubMed Web of Science ®Google Scholar
• Bomford A. B., Munro H. N. Transferrin and its receptor: their roles in cell function. Hepatology 1985; 5: 870–875
   PubMed Web of Science ®Google Scholar
• Young S. P., Bomford A. B., Williams R. The effect of the iron saturation of transferrin on its binding and uptake by rabbit reticulocytes. Biochem. J. 1984; 219: 505–510
   PubMed Web of Science ®Google Scholar
• Nishisato T., Aisen P. Uptake of transferrin by rat peritoneal macrophages. Br. J. Haematol. 1982; 52: 631–640
   PubMed Web of Science ®Google Scholar
• May W. S., Jr., Cuatrecasas P. Transferrin receptor: its biological significance. J. Membr. Biol 1985; 88: 205–215
   PubMed Web of Science ®Google Scholar
• Morgan E. H., Baker E. Role of transferrin receptors and endocytosis in iron uptake by hepatic and erythroid cells. Ann. N.Y. Acad. Sci. 1988; 526: 65–82
   PubMed Web of Science ®Google Scholar
• Irie S., Tavassoli M. Transferrin-mediated cellular iron uptake. Am. J. Med. Sci. 1987; 293: 103–111
   PubMed Web of Science ®Google Scholar
• Casey J. L., Hentze M. W., Koeller D. M., Caughman S. W., Roualt T. A., Klausner R. D., Harford J. B. Iron-responsive elements: regulatory RNA sequences that control mRNA levels and translation. Science 1988; 240: 924–927
   PubMed Web of Science ®Google Scholar
• Testa U., Camagna A., Giannella G., Pelosi-Testa E., Petrini M., Samoggia P., Montesoro E., Bottero L., Sposi N. M., Salvo G., Mavilio F., Isacchi G., Mastroberardino G., Peschle C. Expression of transferrin receptors: differential regulatory mechanisms in monocytes-macrophages versus other hemopoietic cells. Ann. N.Y. Acad. Sci. 1987; 511: 131–137
   PubMed Web of Science ®Google Scholar
• Besancon F., Bourgeade M. -F., Testa U. Inhibition of transferrin receptor expression by interferon-a in human lymphoblastoid cells and mitogen-induced lymphocytes. J, Biol. Chem. 1985; 260: 13074–13080
   PubMed Web of Science ®Google Scholar
• Andreesen R., Sephton R. G., Gadd S., Atkins R. C., DeAbrew S. Human macrophage maturation in vitro: expression of functional transferrin binding sites of high affinity. Blut 1988; 57: 77–83
   PubMedGoogle Scholar
• Lim B. C., McArdle H. J., Morgan E. H. Transferrin-receptor interaction and iron uptake by reticulocytes of vertebrate animals–a comparative study. J. Compar. Physiol. 1987; 157: 363–371
   Web of Science ®Google Scholar
• Davis R. J., Czech M. P. Regulation of transferrin receptor expression at the cell surface by insulin-like growth factors, epidermal growth factor and platelet-derived growth factor. EMBOJ. 1986; 5: 653–658
   PubMed Web of Science ®Google Scholar
• Amouric M., Marvaldi J., Pichon J., Bellot F., Figarella C. Effect of human lactoferrin on the growth of a human colon adenocarcinoma cell line–comparison with transferrin. In Vitro 1984; 20: 543–548
   PubMedGoogle Scholar
• Yamada Y., Amagasaki T., Jacobsen D. W., Green R. Lactoferrin binding by leukemia cell lines. Blood 1987; 70: 264–270
   PubMed Web of Science ®Google Scholar
• Oria R., Alvarez-Hernandez X., Liceaga J., Brock J. H. Uptake and handling of iron from transferrin, lactoferrin and immune complexes by a macrophage cell line. Biochem. J. 1988; 252: 221–225
   PubMed Web of Science ®Google Scholar
• Brock J. H. The effect of iron and transferrin on the response of serum-free cultures of mouse lymphocytes to Concanavalin A and lipopolysaccharide. Immunology 1981; 43: 387–392
   PubMed Web of Science ®Google Scholar
• Page M. A., Baker E., Morgan E. H. Transferrin and iron uptake by rat hepatocytes in culture. Am. J. Physiol 1984; 246: G28–G33
   Google Scholar
• Goto Y., Paterson M., Listowsky I. Iron uptake and regulation of ferritin synthesis by hepatoma cells in hormone-supplemented serum-free media. J. Biol. Chem. 1987; 258: 5248–5255
   Google Scholar
• Brock J. H., Stevenson J. Replacement of transferrin in serum-free cultures of mitogen-stimulated mouse lymphocytes by a lipophilic iron chelator. Immunol. Lttr. 1987; 15: 23–25
   PubMed Web of Science ®Google Scholar
• Chitamber C. R., Zivkovic Z. Support of human leukemic cell growth by iron-pyridoxal isonicotinyl hydrazone (Fe-PIH). Abstr. 8th Internal. Conf. Prot. Iron Storage Transport. Montreal 1987; 60
   Google Scholar
• Landschulz W., Ekblom P. Iron delivery during proliferation and differentiation of kidney tubules. J. Biol. Chem. 1985; 260: 15580–15584
   PubMedGoogle Scholar
• Shivprasad S., Page W. J. Catechol formation and melanization by Na+-dependent Azotobacter chroococcum: a protective mechanism for aeroadaptation?. Appl. Environ. Microbiol 1989; 55: 1811–1817
   PubMed Web of Science ®Google Scholar
• Baldwin D. A., Jenny E. R., Aisen P. The effect of human serum transferrin and milk lactoferrin on hydroxyl radical formation from superoxide and hydrogen peroxide. J. Biol. Chem. 1984; 259: 13391–13394
   PubMed Web of Science ®Google Scholar
• Hershko C., Link G., Pinson A. Modification of iron uptake by hypoxia, ascorbic acid, and α-tocopherol in iron-loaded rat myocardial cell cultures. J. Lab. Clin. Med. 1987; 110: 355–361
   PubMed Web of Science ®Google Scholar
• Theil E. C. Ferritin: structure, gene regulation, and cellular function in animals, plants, and microorganisms. Annu. Rev. Biochem. 1987; 56: 289–315
   PubMed Web of Science ®Google Scholar
• White K., Munro H. N. Induction of ferritin subunit synthesis by iron is regulated at both the transcriptional and translational levels. J. Biol. Chem. 1988; 263: 8938–8942
   PubMed Web of Science ®Google Scholar
• Halliday J. W., Powell L. W. Ferritin and cellular iron metabolism. Ann. N.Y. Acad. Sci. 1988; 526: 101–112
   PubMed Web of Science ®Google Scholar
• Selden C., Owen M., Hopkinds J. M. P., Peters T. J. Studies on the concentration and intracellular localization of iron proteins in liver biopsy specimens from patients with iron overload with special reference to their role in lysosomal disruption. Br. J. Haematol. 1980; 44: 593–603
   PubMed Web of Science ®Google Scholar
• Huebers H. A., Bergamaschi G., Kim B -K., Finch C. A. Observations on the release of iron from cells, Ann. N.Y. Acad. Sci. 1988; 526: 148–154
   PubMed Web of Science ®Google Scholar
• Sibille J. C., Kondo H., Aisen P. Uptake of ferritin and iron bound to ferritin by hepatocytes: modulation by apotransferrin, iron chelators and chloroquine. Biochim. Biophys. Acta 1989; 1013: 204–209
   Google Scholar
• Mostert L. J., de Jong G., Koster J. F., van Eijk G. H. Iron mobilization from isolated hepatocytes. Int. J. Biochem. 1986; 18: 1061–1064
   PubMedGoogle Scholar
• Baynes R. D., Bukofzer G., Bothwell T. H., Bezwoda W. R. Apotransferrin receptors and the delivery of iron from cultured human blood monocytes. Am. J. Hematoi 1987; 25: 417–425
   PubMed Web of Science ®Google Scholar
• Aisen P. Iron metabolism in isolated liver cells. Ann. N.Y. Acad. Sci. 1988; 526: 93–99
   PubMed Web of Science ®Google Scholar
• Hibbs J. B., Jr., Taintor R. R., Vavrin Z. Iron depletion: possible cause of tumor cell cytotoxicity induced by activated macrophages. Biochem. Biophys. Res. Commun. 1984; 123: 716–723
   PubMed Web of Science ®Google Scholar
• Drapier J -C., Hibbs J. B., Jr. Murine cytoxic activated macrophages inhibit aconitase in tumor cells. J. Clin. Invest. 1986; 78: 790–797
   PubMed Web of Science ®Google Scholar
• Wharton M., Granger D. L., Durack D. T. Mitochondrial iron loss from leukemia cells injured by macrophages. J. Immunol 1988; 141: 1311–1317
   PubMed Web of Science ®Google Scholar
• Klostergaard J. Monokine mediated release of intracellular iron in tumor target cells in vitro. Lymphokine Res. 1987; 6: 19–28
   PubMedGoogle Scholar
• Holley R. W. A unifying hypothesis concerning the nature of malignant growth. Proc. Natl. Acad. Sci. USA 1972; 69: 2840–2841
   PubMed Web of Science ®Google Scholar
• Schade S. G. Iron homeostasis in plasmacytoma-bearing mice. Cane. Res. 1976; 36: 375–378
   PubMed Web of Science ®Google Scholar
• Neckers L. M. Transferrin receptors regulate proliferation of normal and malignant B cells. Curr. Top. Micro. Immunol. 1984; 113: 62–68
   PubMed Web of Science ®Google Scholar
• Vostrejs M., Moran P. L., Seligman P. A. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation. J. Clin. Invest. 1988; 82: 331–339
   PubMed Web of Science ®Google Scholar
• Brown J. P., Hewick R. W., Hellstrom I., Hellstrom K. E., Doolittle R. F., Dreyer W. J. Human melanoma-associated antigen p97 L structurally and functionally related to transferrin. Nature 1982; 296: 171–173
   PubMed Web of Science ®Google Scholar
• Basset P., Quesneau Y., Zwiller J. Iron-induced L1210 cell growth: evidence of a transferrin-independent iron transport. Cane. Res. 1986; 46: 1644–1647
   PubMed Web of Science ®Google Scholar
• Gatter K. C., Brown G., Trowbridge I. S., Colston R. E., Mason D. Y. Transferrin receptors in human tissues: their distribution and possible clinical relevance. J. Clin. Pathol 1983; 36: 539–545
   PubMed Web of Science ®Google Scholar
• Faulk W. P., Hsi B. L., Stevens P. L. Transferrin and transferrin receptors in carcinoma of the breast. Lancet 1980; 2: 390–392
   PubMed Web of Science ®Google Scholar
• Shindelman J. E., Ortmeyer A. E., Sussman H. Demonstration of the transferrin receptor in human breast cancer tissue. Int. J. Cane 1981; 27: 329–334
   PubMed Web of Science ®Google Scholar
• Esserman L., Takahashi S., Rojas V., Warnke R., Levy R. An epitope of the transferrin receptor is exposed on the cell surface of high-grade but not low-grade human lymphomas. Blood 1989; 74: 2718–2729
   PubMed Web of Science ®Google Scholar
• Baker E., Jones K., Lloyd D., Morgan E. H., Trinder D., Yeoh G. Comparison of iron metabolism in rat hepatocytes and hepatoma cells in culture. Abstr. 8th Internal Conf. Prot. Iron Trans. Stor. 1987; 66
   Google Scholar
• Niitsu Y., Ohtsuka S., Kohgo Y., Watanabe N., Koseki J., Urushizaki I. Hepatoma ferritin in the tissue and serum. Tumor Res. 1975; 10: 31–42
   Google Scholar
• Zhou X -D., Detolla L., Custer R. P., London W. T. Iron, ferritin, hepatitis B surface and core antigens in the livers of Chinese patients with hepatocellular carcinoma. Cancer 1987; 59: 1430–1437
   PubMed Web of Science ®Google Scholar
• Westmacott D., Hawkes J. E., Hill R. P., Clarke L. E., Bloxham D. P. Comparison of the effects of recombinant murine and human interleukin-1 in vitro and in vivo. Lymphokine Res. 1986; 5(Suppl. 1)S87–S91
   Google Scholar
• Alvarez-Hernandez X., Liceaga J., McKay I. C., Brock J. H. Induction of hypoferremia and modulation of iron metabolism by tumor necrosis factor. Lab. Invest. 1989; 61: 319–326
   PubMed Web of Science ®Google Scholar
• Konijn A. M., Hershko C. The anaemia of inflammation and chronic disease. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley and Sons, Ltd., Chichester 1989; 111–143
   Google Scholar
• Esaguy N., Aguas A. P., Silva M. T. High-resolution localization of lactoferrin in human neutrophilis: labeling of secondary granules and cell heterogeneity. J. Leuk. Biol. 1989; 46: 51–62
   PubMed Web of Science ®Google Scholar
• MoUoy A. L., Winterboume C. C. Release of iron from phagocytosed Escherichia coli and uptake by neutrophil lactoferrin. Blood 1990; 75: 984–989
   PubMed Web of Science ®Google Scholar
• Alvarez-Hernandez X., Felstein M. V., Brock J. H. The relationship between iron release, ferritin synthesis, and intracellular iron distribution in mouse peritoneal macrophages. Biophys. Acta 1986; 886: 214–222
   PubMed Web of Science ®Google Scholar
• Birgens H. S., Kristensen L. O., Borregaard N., Karle H., Hansen N. E. Lactoferrin-mediated transfer of iron to intracellular ferritin in human monocytes. Eur. J. Haematol. 1988; 41: 52–57
   PubMed Web of Science ®Google Scholar
• Lima M. F., Kierszenbaum F. Lactoferrin effects on phagocytic cell function. J. Immunol 1987; 139: 1647–1651
   PubMed Web of Science ®Google Scholar
• Hamilton T. A., Gray P. W., Adams D. O. Expression of the transferrin receptor on murine peritoneal macrophages is modulated by in vitro treatment with interferon gamma. Cellu. Immunol. 1984; 89: 478–488
   PubMed Web of Science ®Google Scholar
• Byrd T. F., Horwitz M. A. Interferon gamma-activated human monocytes down regulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 1989; 83: 1457–1465
   PubMed Web of Science ®Google Scholar
• Taetle R., Honeysett J. M. Gamma-interferon modulates human monocyte/macrophage transferrin receptor expression. Blood 1988; 71: 1590–1595
   PubMed Web of Science ®Google Scholar
• Lum J. B., Infante A. J., Makker D. M., Yang F., Bowman B. H. Transferrin synthesis by inducer T lymphocytes. J. Clin. Invest 1986; 77: 841–849
   PubMed Web of Science ®Google Scholar
• Arthur C. K., Isbister J. P. Iron deficiency–misunderstood, misdiagnosed, and mistreated. Drugs 1987; 33: 171–182
   PubMed Web of Science ®Google Scholar
• Roche M., Perez-Giminez M. E., Layrisse M., DiFrisco E. Study of urinary and fecal excretion of Cr51 in man. Its use in the measurement of intestinal blood loss associated with hookworm infection. J. Clin. Invest. 1957; 36: 1183–1192
   PubMed Web of Science ®Google Scholar
• Crosby W. H. Who needs iron?. N. Engl. J. Med. 1977; 297: 543–545
   PubMed Web of Science ®Google Scholar
• Wadsworth G. Nutritional factors in anaemia. World Rev. Nutr. Diet. 1975; 21: 75–150
   PubMedGoogle Scholar
• Elwood P. C., Hughes D. Clinical trial of iron therapy on psychomotor function in anaemic women. Br. Med. J. 1970; 3: 254–255
   PubMed Web of Science ®Google Scholar
• Cook J. D., Skikne B. S., Lynch S. R., Reusser M. E. Estimates of iron sufficiency in the U.S. population. Blood 1986; 68: 726–731
   PubMed Web of Science ®Google Scholar
• Krikker M. A. Iron fortification–continuing controversy. Nutr. Today 1987; 22: 37–38
   Google Scholar
• Bothwell T. H., Charlton R., Motulsky A. G. Hemochromatosis. The Metabolic Basis of Inherited Disease6th ed., C. R. Scriver, A. L. Beaudet, W. S. Sly, D. Valle. McGraw Information Sciences, Co., New York 1989; 1433–1462
   Google Scholar
• Kent S., Weinberg E. D., Stuart-Macadam P. Dietary and medical prophylactic iron supplements: helpful or harmful?. Human Nature 1990; 1: 55–81
   Google Scholar
• Lynch S. R., Hurrell R. E. Iron in formulas and baby foods. Iron Metabolism in Infants, B. Lonnerdal. CRC Press, Boca Raton, FL 1990; 110–126
   Google Scholar
• Walter T., Olivares M., Hertrampf E. Field trials of food fortification with iron: the experience in Chile. Iron Metabolism in Infants, B. Lonnerdal. CRC Press, Boca Raton, FL 1990; 127–155
   Google Scholar
• Crosby W. H. Hemochromatosis: current concepts and management. Hosp. Pract. 1987; 22: 173–192
   Web of Science ®Google Scholar
• Chapman R. W., Morgan M. Y., Laulicht M., Hoffbrand A. V., Sherlock S. Hepatic iron stores and markers of iron overload in alcoholics and patients with idiopathic hemochromatosis. Dig. Dis. ScL 1982; 27: 909–916
   PubMed Web of Science ®Google Scholar
• Jacobs P., Bothwell T., Charlton R. W. Role of hydrochloric acid in iron absorption. J. Appl. Physiol. 1964; 19: 187–188
   PubMed Web of Science ®Google Scholar
• Mazzanti R., Srai K. S., Debnam E. S., Boss A. M., Gentilini P. The effect of chronic ethanol consumption on iron absorption in rats. Alcohol Alcohol 1987; 22: 47–52
   PubMed Web of Science ®Google Scholar
• Kapur A., Wild G., Milford-Ward A., Triger D. R. Carbohydrate deficient transferrin: a marker for alcohol abuse. Br. Med. J. 1989; 299: 427–431
   PubMed Web of Science ®Google Scholar
• Simon M., Bourel M., Genetet B., Fauchet R. Idiopathic hemochromatosis: demonstration of recessive transmission and early detection by family HLA typing. N. Engl. J. Med. 1977; 297: 1017–1021
   PubMed Web of Science ®Google Scholar
• Bassett M. L., Doran T. J., Halliday J. W., Bashir H. V., Powell L. W. Idiopathic hemochromatosis: demonstration of homozygous heterozygous mating by HLA typing of families. Hum. Genet. 1982; 60: 352–356
   PubMed Web of Science ®Google Scholar
• Olsson K. S., Ritter B., Rosen U., Heedman P. A., Staugard F. Prevalence of iron overload in Central Sweden. Acta Med. Scand. 1983; 213: 145–150
   PubMed Web of Science ®Google Scholar
• Edwards C. Q., Griffen L. M., Goldgar D., Drummond C., Skolnick M. H., Kushner J. P. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N. Engl. J. Med. 1988; 318: 1355–1362
   PubMed Web of Science ®Google Scholar
• Phelps G., Chapman I., Hall P., Braund W., Mackinnon M. Prevalence of genetic haemochromatosis among diabetic patients. Lancet 1989; 2: 233–234
   PubMed Web of Science ®Google Scholar
• Lombard M., Bomford A., Hynes M., Naomuv N. V., Roberts S., Crowe J., Roberts S. Regulation of the hepatic transferrin receptor in hereditary hemochromatosis. Hepatology 1989; 9: 1–5
   PubMed Web of Science ®Google Scholar
• Mahoney J. R., Jr., Hallaway P. E., Hedlund B. E., Eaton J. W. Acture iron poisoning. J. Clin. Invest. 1989; 84: 1362–1366
   PubMed Web of Science ®Google Scholar
• Lynch S. R., Cook J. D. Interaction of vitamin C and iron, Awn. N.Y. Acad. Sci. 1980; 355: 32–44
   PubMedGoogle Scholar
• Cook J. D., Watson S. S., Simpson K. M., Lipschitz D. A., Skikne B. S. The effect of high ascorbic acid supplementation on body iron stores. Blood 1984; 64: 721–726
   PubMed Web of Science ®Google Scholar
• Nienhuis A. W. Vitamin C and iron. N. Engl. J. Med. 1981; 304: 170–171
   PubMed Web of Science ®Google Scholar
• Stich H. F., Wei L., Whiting R. F. Enhancement of the chromosome-damaging action of ascorbate by transition metals. Cane. Res. 1979; 39: 4145–4151
   PubMed Web of Science ®Google Scholar
• Tonz O., Weiss S., Strahm H. W., Rossi E. Iron absorption in cystic fibrosis. Lancet 1965; 2: 1096–1099
   PubMed Web of Science ®Google Scholar
• Hershko C. Storage iron regulation. Prog. Hematol 1977; 10: 105–147
   PubMedGoogle Scholar
• Erlandson M. E., Walden B., Stern G., Hilgartner M. W., Wehman J., Smith C. H. Studies on congenital hemolytic syndrome. IV. Gastrointestinal absorption of iron. Blood 1962; 19: 359–369
   PubMed Web of Science ®Google Scholar
• Parkin J. D., Rush B., deGroot R. J., Budd R. S. Iron absorption after splenectomy in hereditary spherocytosis. Austral. N. Z. J. Med. 1974; 4: 58–61
   PubMedGoogle Scholar
• Pootrakul P., Rugiatsakul R., Wasi P. Increased transferrin iron saturation in splenectomized thalassemic patients. Br. J. Haematol 1980; 46: 143–145
   PubMed Web of Science ®Google Scholar
• Hershko C. Oral chelating drugs: coming but not yet ready for clinical use. Br. Med. J. 1988; 296: 1081–1082
   PubMed Web of Science ®Google Scholar
• McLaren G. D., Muir W. A., Kellerman R. W. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. CRC Clin. Rev. Lab. ScL 1983; 19: 205–266
   PubMed Web of Science ®Google Scholar
• Antoine D., Braun P., Cervoni P., Schwartz P., Lamy P. Le cancer bronchique des mineurs de fer de Lorraine peutil etre considere comme une maladie professionelle?. Rev. Fr. Maladie Respiratoire 1979; 7: 63–65
   PubMedGoogle Scholar
• Cordes L. C., Brink E. W., Checko P. J., Lentner A., Lyons R. W., Hayes P. S., Wu T. C., Tharr D. G., Fraser D. W. A cluster of Acinetobacter pneumonia in foundry workers. Ann. Intern. Med. 1981; 95: 688–693
   PubMed Web of Science ®Google Scholar
• Dreyfus J. R. Lungencarcinoma bei Geschwistera nach Inhalation von Eisenoxyhaltigen Staub der Jugend. Zeits. Klin. Med. 1936; 130: 256–260
   Google Scholar
• Weinberg E. D. Iron, asbestos, and carcinogenicity. Lancet 1989; 1: 1399–1400
   PubMed Web of Science ®Google Scholar
• McGowan S. E., Henley S. A. Iron and ferritin contents and distribution in human alveolar macrophages. J. Lab. Clin. Med., Ill 1988; 611–617
   Google Scholar
• Forrest R. D., Jackson C. A., Yudkin J. S. The epidemiology of the haemoglobin level–a study of 1057 subjects in general practice. Postgrad. Med. J. 1987; 63: 625–628
   PubMed Web of Science ®Google Scholar
• Sethi V. S., Shihabi Z., Spurr C. L. Increase of serum iron concentrations in Rhesus monkeys and humans on administration of vincristine, vinblastine, or vindesine. Cane. Treat. Repts. 1984; 68: 933–936
   PubMedGoogle Scholar
• Thein M., Beaton G. H., Milne H., Veen M. J. Oral contraceptive drugs: some observations on their effect on menstrual loss and hematological indices. Canad. Med. Assoc. J. 1969; 101: 73–76
   Google Scholar
• Frassinelli-Gunderson E. P., Margen S., Brown J. R. Iron storage in users of oral contraceptive agents. Am. J. Clin. Nutr. 1985; 41: 703–712
   PubMed Web of Science ®Google Scholar
• Olusi S. O., McFarlane H. Iron therapy and refeeding in experimentally malnourished rats. Ped. Res. 1978; 12: 625–630
   PubMed Web of Science ®Google Scholar
• Pickleman J. R., Evans L. S., Kane J. K., Freeark R. J. Tuberculosis after jejunoileal bypass for obesity. J. Am. Med. Assn. 1975; 234: 744–744
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. Iron and susceptibility to infectious disease. Science 1974; 184: 952–956
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. Iron and infection. Microbiol Revs. 1978; 42: 45–66
   PubMedGoogle Scholar
• Schryvers A. B., Gonzalez G. C. Comparison of the abilities of different protein sources of iron to enhance Neisseria meningitidis infection in mice. Infec. Immun. 1989; 57: 2425–2429
   PubMed Web of Science ®Google Scholar
• van Asbeck B. S., Marx J. J. M., Struyvenberg A., Verhoef J. Functional defects in phagocytic cells from patients with iron overload. J. Infec 1984; 8: 232–240
   PubMed Web of Science ®Google Scholar
• Waterlot Y., Cantinieaux B., Hariga-Muller C., de Maertelaere-Laurent E., Vanherweghem J. L., Fondu P. Impaired phagocytic activity of neutrophils in patients receiving hemodialysis: the critical role of iron overload. Br. Med. J. 1985; 291: 503–504
   Google Scholar
• Ballart I. J., Estevez N. E., Sen L., Diez R. A., Giuntoli J., de Miani S. A., Penalver J. Progressive dysfunction of monocytes associated with iron overload and age in patients with thalassemia major. Blood 1986; 67: 105–109
   PubMed Web of Science ®Google Scholar
• de Sousa M. Lymphoid cell positioning: a new proposal for the mechanism of control of lymphoid cell migration. Symp. Soc. Exp. Biol 1978; 32: 393–409
   PubMedGoogle Scholar
• Good M. F., Chapman D. E., Powell L. W., Halliday J. W. The effect of experimental iron-overload on splenic T cell function: analysis using clonal techniques. Clin. Exp. Immunol 1987; 68: 375–383
   PubMed Web of Science ®Google Scholar
• Pardolos G., Kanakoudi-Tsakalidis F., Malaka-Zafiriu M., Tsantali H., Athanasiou-Metaxa M., Kallinikos G., Papaenangelou G. Iron-related disturbances in multitransfused children. Clin. Exp. Immunol 1987; 68: 138–143
   PubMed Web of Science ®Google Scholar
• Kaplan J., Sarnaik S., Gitlin J., Lusher J. Diminished helper/suppressor lymphocyte ratios and natural killer activity in recipients of repeated blood transfusions. Blood 1984; 64: 308–310
   PubMed Web of Science ®Google Scholar
• Green R., Esperaza I., Schreiber R. Iron inhibits the nonspecific tumorcidal activity of macrophages, Ann. N.Y. Acad. Sci. 1988; 526: 301–309
   PubMed Web of Science ®Google Scholar
• Brock J. H. Iron and cells of the immune system. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley and Sons, Ltd., Chichester 1989; 81–108
   Google Scholar
• Zurlo M. G., De Stefano P., Borgna-Pignatti C., Di Palma A., Piga A., Melevendi C., Di Gregorio F., Burattini M., Terzoli S. Survival and causes of death in thalassemia major. Lancet 1989; 2: 27–30
   PubMed Web of Science ®Google Scholar
• Boelaert J. R., van Landuyt H. W., Valcke Y. J., Cantinieaux B., Lornoy W. F., Vanherweghem J -L., Moreillon P., Vandepitte J. M. The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients. J. Infec. Dis. 1987; 156: 384–387
   PubMed Web of Science ®Google Scholar
• Barry D. M. J., Reeve A. W. Increased incidence of gram negative neonatal sepsis with intramuscular iron administration. Pediatrics 1977; 60: 908–912
   PubMed Web of Science ®Google Scholar
• Oppenheimer S. J., Gilson F. D., MacFarlane S. B., Moody J. B., Harrison C., Spencer A., Bunari O. Iron supplementation increases prevalence and effects of malaria: report on clinical studies in Papua, New Guinea. Trans. Roy. Soc. Trop. Med. Hyg. 1986; 80: 603–612
   PubMed Web of Science ®Google Scholar
• Weinberg E. D. DF-2 sepsis, a sequela of sideremia. Med. Hypoth. 1987; 24: 287–289
   PubMed Web of Science ®Google Scholar
• Tustin A. W., Kaiser A. B., Bradsher R. W., Herrington J. L. Unusual fungal infections following jejunoileal bypass surgery. Arch. Intern. Med. 1980; 140: 643–645
   PubMed Web of Science ®Google Scholar
• Berman C. Primary carcinoma of the liver. Adv. Cane. Res. 1958; 5: 55–96
   Web of Science ®Google Scholar
• Robertson M. A., Harrington J. S., Bradshaw E. The cancer pattern in African gold mines. Br. J. Cane 1971; 25: 395–402
   PubMed Web of Science ®Google Scholar
• Niederau C., Fischer R., Sonnenberg A., Stremmel W., Trampisch H. J., Strohmeyer G. Survival and causes of death in cirrhotic and in non-cirrhotic patients with primary hemochromatosis. N. Engl. J. Med. 1985; 313: 1256–1262
   PubMed Web of Science ®Google Scholar
• Lustbader E. D., Hann H. -W.L., Blumberg B. S. Serum ferritin as a predictor of host response to hepatitis B virus infection. Science 1983; 220: 423–425
   PubMed Web of Science ®Google Scholar
• Berman J. J. Cell proliferation and the aetiology of hepatocellular carcinoma. J. Hepatol 1988; 7: 305–309
   PubMed Web of Science ®Google Scholar
• Israel J. L., McGlynn K. A., Hann H. -W. L., Blumberg B. S. Iron-related markers in liver cancer. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley and Sons, Ltd., Chichester 1989; 301–316
   Google Scholar
• Hann H. -W. L., Stahlhut M. W., Blumberg B. S. Iron nutrition and tumor growth: decreased tumor growth in iron-deficient mice. Cane. Res. 1988; 48: 4168–4170
   PubMed Web of Science ®Google Scholar
• Siegers C. -P., Bumann D., Baretton G., Younes M. Dietary iron enhances the tumor rate in dimethylhydrazine-induced colon carcinogenesis in mice. Cane. Lttrs. 1988; 41: 251–256
   PubMed Web of Science ®Google Scholar
• Benbassat J., Hershko C., Laskov R., Eliakim M. Effect of iron deficiency on transplantable murine plasmacytoma. Nutr. Cane 1981; 3: 20–26
   PubMedGoogle Scholar
• Bergeron R. J., Streiff R. R., Elliott G. T. Influence of iron on in vivo proliferation and lethality of L1210 cells. J. Nutr. 1985; 115: 369–374
   PubMed Web of Science ®Google Scholar
• Evans A. E., D'Angio G. J., Propert K., Anderson J., Hann H. -W. L. Prognostic factors in neuroblastoma. Cancer 1987; 59: 1853–1859
   PubMed Web of Science ®Google Scholar
• Stevens R. G., Beasley R. P., Blumberg B. S. Iron-binding proteins and risk of cancer in Taiwan. J. Natl. Cane. Inst. 1986; 76: 605–610
   PubMed Web of Science ®Google Scholar
• Hann H. -W. L., Kim C. Y., London W. T., Blumberg B. S. Increased serum ferritin in chronic liver disease: a risk factor for primary hepatocellular carcinoma. Internat. J. Cane. 1989; 43: 376–379
   PubMed Web of Science ®Google Scholar
• Potaznik D., Groshen S., Miller D., Bagin R., Bhalla R., Schwartz M., de Sousa M. Association of serum iron, serum transferrin saturation, and serum ferritin with survival in acute lymphocytic leukemia. Am. J. Ped. HematoL/Oncol. 1987; 9: 350–355
   PubMed Web of Science ®Google Scholar
• Stevens R. G., Jones D. Y., Micozzi M. C., Taylor P. R. Body iron stores and risk of cancer. N. Engl. J. Med. 1988; 319: 1047–1052
   PubMed Web of Science ®Google Scholar
• Selby J. V., Friedman G. D. Epidemiologic evidence of an association between body iron stores and risk of cancer. Internat. J. Cane. 1988; 41: 677–682
   PubMed Web of Science ®Google Scholar
• Akiba S., Nerlishi K., Blot W. J., Kabuto M., Stevens R. G., Kato H., Land C. E. Serum ferritin and stomach cancer risk among Japanese, Submitted
   Google Scholar
• Buja L. M., Roberts W. C. Iron in the heart. Am. J. Med. 1971; 51: 209–221
   PubMed Web of Science ®Google Scholar
• Neffgen J. F., Rakusan K. Iron supplementation in suckling rats: its effect on the heart. Rec. Adv. Stud. Card. Struct. Metab. 1975; 10: 707–716
   PubMedGoogle Scholar
• Artman M., Olson R. D., Boucek R. J., Jr., Boerth R. C. Depression of contractility in isolated rabbit myocardium following exposure to iron: role of free radicals. Toxicol. Appl. Pharmacol 1984; 72: 324–332
   PubMed Web of Science ®Google Scholar
• Wicomb W. N., Cooper D. K. C., Novitzky D. Loss of myocardial viability following hypothermic perfusion storage from contaminating trace elements in the perfusate. Transplantation 1987; 43: 23–28
   PubMed Web of Science ®Google Scholar
• Sullivan J. L. The iron paradigm of ischemic heart disease. Am. Heart J. 1989; 117: 1177–1188
   PubMed Web of Science ®Google Scholar
• Reddy B. R., Kloner R. A., Przyklenk K. Early treatment with deferoxamine limits myocardial ischemic/reperfusion injury. Free Rad. Biol. Med. 1989; 7: 45–52
   PubMed Web of Science ®Google Scholar
• Henry W. Echocardiography evaluation of the heart in thalassemic major, Ann. Intern. Med. 1979; 91: 892–894
   Google Scholar
• Monteiro H. P., Vile G. F., Winterburne C. C. Release of iron from ferritin by semiquinone, anthracycline, bipyridyl, and nitroaromatic radicals. Free Rod. Biol. Med 1989; 6: 587–591
   PubMed Web of Science ®Google Scholar
• Aust S. D., Morehouse L. A., Thomas C. E. Roles of metals in oxygen radical reactions. J. Free Rad. Biol. Med. 1985; 1: 3–25
   PubMedGoogle Scholar
• Sullivan J. L. The sex differences in ischemic heart disease. Persp. Biol. Med. 1983; 26: 657–671
   PubMed Web of Science ®Google Scholar
• Slone D., Shapiro S., Kaufman D., Rosenberg L., Miettinen O. S., Stolley P. D. Risk of myocardial infarction in relation to current and discontinued use of oral contraceptives, #. Engl. J. Med. 1981; 305: 420–424
   PubMed Web of Science ®Google Scholar
• Biemond P., Swaak A. J. C., van Euk H. C., Koster J. F. Superoxide dependent iron release from ferritin in inflammatory diseases. J. Free Rad. Biol. Med. 1988; 4: 185–198
   Google Scholar
• Winyard P. G., Blake D. R., Chirico S., Gutteridge J. M. C., Lunec J. Mechanism of exacerbation of rheumatoid synovitis by total-dose iron-dextran infusion: in vivo demonstration of iron-promoted oxidant stress. Lancet 1987; 1: 69–72
   PubMed Web of Science ®Google Scholar
• Blake D. R., Hall N. D., Bacon P. A., Dieppe P. A., Halliwell B., Gutteridge J. M. C. The importance of iron in rheumatoid disease. Lancet 1981; 2: 1142–1143
   PubMed Web of Science ®Google Scholar
• Andrews F. J., Blake D. R., Morris C. J. Iron and joint inflammation. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley and Sons, Ltd., Chichester 1989; 145–175
   Google Scholar
• Shagin J. W., Frame B., Duncan H. Polyarthritis in obese patients with intestinal bypass. Ann. Intern. Med. 1971; 75: 377–380
   PubMed Web of Science ®Google Scholar
• Schafer A. I., Cheron R. G., Dluby R., Cooper B., Gleason R. E., Soeldner J. S., Bunn H. F. Clinical pathological consequences of acquired transfusional overload in adults. N. Engl. J. Med. 1981; 304: 319–324
   PubMed Web of Science ®Google Scholar
• Milder M. S., Cook J. D., Stray S., Finch C. A. Idiopathic hemochromatosis, an interim report. Medicine 1980; 59: 34–49
   PubMed Web of Science ®Google Scholar
• Siemons L. J., Mahler C. Hypogonadotropic hypogonadism in hemochromatosis: recovery of reproductive function after iron depletion. J. Clin. Endocrinol. Metab. 1987; 65: 585–587
   PubMed Web of Science ®Google Scholar
• Are “wholesome” food and water good enough?. Lancet 1983; 2: 715–716, Anon.
   PubMed Web of Science ®Google Scholar
• de Sousa M., Potaznik D. Proteins of the metabolism of iron, cells of the immune system, and malignancy. Vitamins, Minerals, and Cancer, D. Prasad. Karger, Basel 1984; 231–239
   Google Scholar
• Crosby W. H. Yin, yang, and iron. Nutr. Today 1986; 21: 14–16
   Google Scholar
• Graf E., Eaton J. W. Antioxidant function of phytic acid. Free Rad. Biol. Med. 1990; 8: 61–69
   PubMed Web of Science ®Google Scholar
• Hallberg L., Rossander L., Skanberg A. -B. Phytates and the inhibitory effect of bran on iron absorption in man, Am. J. Clin. Nutr. 1987; 45: 988–996
   Google Scholar
• de Alarcon P. A., Donovan M. -E., Forbes G. B., Landaw S. A., Stockman J. A. Iron absorption in the thalassemia syndromes and its inhibition by tea. N. Engl. J. Med. 1979; 300: 5–8
   PubMed Web of Science ®Google Scholar
• Cook J. D. Adaptation in iron metabolism. Am. J. Clin. Nutr. 1990; 51: 301–308
   PubMed Web of Science ®Google Scholar
• Hibbard B. M. Iron and folate supplements during pregnancy: supplementation is valuable only in selected patients. Br. Med. J. 1988; 297: 1324–1326
   PubMed Web of Science ®Google Scholar
• Hemminski E., Starfield B. Routine administration of iron and vitamins during pregnancy: review of controlled clinical trials. Br. J. Obstet. Gynecol 1978; 85: 404–410
   PubMedGoogle Scholar
• Garn S. M., Keating M. T., Falkner F. Hematological status and pregnancy outcomes. Am. J. Clin. Nutr. 1981; 34: 115–117
   PubMed Web of Science ®Google Scholar
• Koller O., Sandvei R., Sagen N. High hemoglobin levels during pregnancy and fetal risk. Internal J. Gynaecol. Obstet. 1980; 18: 53–56
   PubMedGoogle Scholar
• Oski F. A. Anemia in children. Hosp. Pract. 1976; 11: 63–72
   PubMedGoogle Scholar
• Duncan B., Schifman R. B., Corrigan J. J., Jr., Schaefer C. Iron and the exclusively breast-fed infant from birth to six months. J. Ped. Gastroenterol. Nutr. 1985; 4: 421–425
   PubMed Web of Science ®Google Scholar
• Siimes M. A., Salmenpera L., Perheentopa J. Exclusive breast feeding for nine months: risk of iron deficiency. J. Ped. 1984; 104: 196–199
   PubMed Web of Science ®Google Scholar
• Weinberg R. J., Ell S. R., Weinberg E. D. Blood-letting, iron homeostasis, and human health. Med. Hypoth. 1986; 21: 441–443
   PubMed Web of Science ®Google Scholar
• Erythropoietin reaches the pharmacy. Lancet 1989; 2: 1252–1254, Anonymous
   PubMed Web of Science ®Google Scholar
• Eschbach J. W., Egrie J. C., Downing M. R., Browne J. K., Adamson J. W. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. N. Engl. J. Med. 1987; 316: 73–78
   PubMed Web of Science ®Google Scholar
• McCarthy J. T., Johnson W. J., Nixon D. E., Jenson B. M., Moyer T. P. Transfusional iron overload in patients undergoing dialysis: treatment with erythropoietin and phlebotomy. J. Lab. Clin. Med. 1989; 114: 193–199
   PubMed Web of Science ®Google Scholar
• Elwood P. C., Waters W. E., Benjamin I. T., Sweetman P. M. Mortality and anaemia in women. Lancet 1974; 1: 891–894
   PubMed Web of Science ®Google Scholar
• Ley T. J., Nienhuis A. W. Chelation therapy for transfusion dependent adults. N. Engl. J. Med. 1983; 308: 1422–1423
   PubMed Web of Science ®Google Scholar
• Cutler P. Deferoxamine therapy in high-ferritin diabetes. Diabetes 1989; 38: 1207–1210
   PubMed Web of Science ®Google Scholar
• Halliwell B. ICRF-187 and doxorubicin-induced cardiac toxicity. N. Engl. J. Med. 1989; 320: 399
   Web of Science ®Google Scholar
• Kontoghiorghes G. J., Nasseri-Sina P., Goddard J. G., Barr J. M., Nortey P., Sheppard L. N. Safety of oral iron chelator LI. Lancet 1989; 2: 457–458
   Web of Science ®Google Scholar
• Pippard M. J. Clinical use of iron chelators. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley and Sons, Ltd., Chichester 1989; 361–392
   Google Scholar
• Porter J. B., Huehns E. R., Hider R. C. The development of iron chelating drugs. Bailliere's Clin. Haematol. 1989; 2: 257–292
   PubMedGoogle Scholar
• Porter J. B., Hoyes K. P., Abeysinghe R., Huehns E. R., Hider R. C. Animal toxicology of iron chelator LI. Lancet 1989; 2: 156
   PubMed Web of Science ®Google Scholar
• Oral iron chelators. Lancet 1989; 2: 1016–1017, Anonymous
   PubMed Web of Science ®Google Scholar
• Agarwal M. B., Viswanathan C., Ramanathan J., Massil D. E., Shah S., Gupta S. S., Vasandani D., puniyani R. R. Oral iron chelation with LI. Lancet 1990; 335: 601
   PubMed Web of Science ®Google Scholar
• Kontoghiorghes G. J., Hoffbrand A. V. Clinical trials with oral iron chelator LI. Lancet 1989; 2: 1516–1517
   PubMed Web of Science ®Google Scholar
• Yinnon A. M., Theanacho E. N., Grady R. W., Spira D. T., Hershko C. Antimalarial effect of HBED and other phenolic and catecholic iron chelators. Blood 1989; 74: 2166–2171
   PubMed Web of Science ®Google Scholar
• Bergeron R. J., Ingeno M. J. Microbial iron chelator-induced cell cycle syncronization in L1210 cells: potential in combination chemotherapy. Cane. Res. 1987; 47: 6010–6016
   PubMed Web of Science ®Google Scholar
• Bergeron R. J., Braylan R., Goldey S., Ingeno M. J. Effects of the Vibrio cholerae siderophore vibriobactin on the growth characteristics of L1210 cells. Biochem. Biophys. Res. Commun. 1986; 136: 273–280
   PubMed Web of Science ®Google Scholar
• Cavanaugh P. F., Jr., Porter C. W., Tukalo D., Frankfurt O. S., Pavelic Z. P., Bergeron R. J. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II. Cane. Res. 1985; 45: 4754–4759
   PubMed Web of Science ®Google Scholar
• Hallaway P. E., Eaton J. W., Panter S. S., Hedlund B. E. Modulation of deferoxamine toxicity and clearance by covalent attachment to biocampatible polymers. Proc. Natl. Acad. Sci. USA 1989; 86: 10108–10112
   PubMed Web of Science ®Google Scholar
• Dezza L., Bergamaschi G., Cazzola M., Stella C., Danova M., Invenizzi R., Ascari E. Antiproliferative properties of desferoxamine on normal and and leukemic hemopoietic cell growth. Abstr. 8th Internal Conf. Prot. Iron Transport Storage. 1987; 73
   Google Scholar
• Hann H. -L., Stahlhut M. W., London W. T. Anti-tumor activity of an iron chelating agent (desferoxamine) on human hepatoma cell lines. Clin. Res. 1988; 36: 495
   Google Scholar
• Blatt J., Taylor S. R., Stitely S. Mechanism of antineuroblastoma activity of deferoxamine in vitro. J. Lab. Clin. Med. 1988; 112: 433–436
   PubMedGoogle Scholar
• Lederman H. M., Cohen A., Lee J. W. W., Freedman M. H., Gelfand E. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 1984; 64: 748–753
   PubMed Web of Science ®Google Scholar
• Trowbridge I. S. Potential clinical uses of anti-transferrin receptor monoclonal antibodies. Iron in Immunity, Cancer, and Inflammation, M. de Sousa, J. H. Brock. J. Wiley & Sons, Ltd., Chichester 1989; 341–360
   Google Scholar
• Kletter G., Parks B. R., Jr., Bhatnagar A., Iyer R. V. Elevated serum iron levels following administration of cisplatinum. Oncology 1988; 45: 421–423
   PubMed Web of Science ®Google Scholar
• Morgan E. H., lacopetta B. J. Vinblastine but not other microtubule inhibitors blocks transferrin endocytosis and iron uptake by reticulocytes. Clin. Exp. Pharmacol. Physiol. 1987; 14: 119–126
   PubMed Web of Science ®Google Scholar
• Chitambar C. R., Seigneuret M. C., Matthaeus W. G., Lum L. G. Modulation of lymphocyte proliferation and immunoglobulin production by transferrin-gallium. Cane. Res. 1989; 49: 1125–1129
   PubMed Web of Science ®Google Scholar
• Black J. R., Dyer D. W., Thompson M. K., Sparling P. F. Human immune response to iron-repressible outer membrane proteins of. Neisseria meningitidis, Infec. Immun. 1986; 54: 710–713
   PubMed Web of Science ®Google Scholar
• Shand G. H., Anwar H., Kadurugamuwa J., Brown M. R. W., Silverman S. H., Melling J. In vivo evidence that bacteria in urinary tract infection grow under iron-restricted conditions. Infec. Immun. 1985; 48: 35–39
   PubMed Web of Science ®Google Scholar